| NEI Psychopharmacology Congress |
|
|
|
The Age Of Personalized Medicine: The Role Of Pharmacogenetics
Stephen M Stahl, MD, PhD
Personalized medicine involves tailoring preventative and therapeutic interventions to the individual characteristics of a patient. Our knowledge of the genetic contributions to numerous diseases is increasing exponentially; it is likely that in the near future virtually all health care will be personalized at the level of the genome. In this presentation, Dr. Stephen Stahl provides an update on the benefits and limitations of personalized medicine.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Treatment Modification In Major Depressive Disorder: Dosing, Switching, And Augmentation
Thomas L Schwartz, MD
In this presentation, Dr. Thomas Schwartz provides an update on recent advances on understanding the mechanisms of depression, new therapeutic targets, existing and new treatment combinations, and tests to improve the efficacy of and adherence to treatments for patients with inadequate response to antidepressants.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Applying Antipsychotic Pharmacokinetics to Best Dosing Practices: Depot Medications
Jonathan M Meyer, MD
The pharmacokinetic properties of a medication can be as important as its efficacy in determining how successful a treatment is. Pharmacokinetics are particularly important when switching to and maintaining long-acting injectable antipsychotics. In this presentation, Dr. Jonathan Meyer explains how to use the pharmacokinetic properties of long-acting injectable antipsychotics to guide decisions regarding the initiation and maintenance of dosing these agents.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Lightning Round: Differential Diagnosis of Depressive States
Stephen M Stahl, MD, PhD
Several disorders, including bipolar depression, mixed depression, and pseudobulbar affect (PBA) often resemble, and are misdiagnosed as, major depressive disorder (MDD). Misdiagnosis of any of these disorders can result in less than optimal treatment for patients, and negative consequences. In this lecture, Dr. Stephen M. Stahl addresses evidence-based strategies to differently diagnose patients presenting in a depressive state with symptoms that resemble depression.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Fear Not!! Naming, Framing, And Containing The Physiology Of Fear...a Wellness Approach
Mary D Moller, DNP, PhD, ARNP, PMHCNS
Up to 70% of adults in the U.S. will experience at least one traumatic event in their lives, and up to 20% of these people will go on to develop Post Traumatic Stress Disorder (PTSD). This suggests that approximately 44.7 million people have or are currently struggling with PTSD. In this lecture, Mary Moller discusses the biological, social, and spiritual consequences that fear disorders can have. She presents the most current information on evidence-based wellness strategies to manage fear and improve the quality of life for those who suffer from PTSD.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Psychosis: Challenging Issues in Parkinson's Disease and Other Neurodegenerative Disorders
Jonathan M Meyer, MD
In this presentation, Dr. Jonathan Meyer discusses psychosis in the context of Parkinson's and Alzheimer's diseases. Strategies for managing these patients will also be explored.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Successful Aging as The Brain Changes: This is Your Brain on Life
Stephen M Stahl, MD, PhD
The normal aging process alters the adult brain in many different ways, however lifestyle behaviors such as proper nutrition and exercise can slow the aging process and preserve brain health. In this lecture, Dr. Stephen Stahl addresses the most current scientific research on how healthy lifestyle behaviors influence the brain in positive ways.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Understanding Disease Models and Treatment Opportunities: Lessons from Metabolism and Inflammation
Roger S McIntyre, MD, FRCPC
The immune inflammatory system is in interplay with other systems relevant to psychopathology and resiliency, playing both an adaptive and maladaptive role. Correspondingly, there is emerging evidence that mechanistically dissimilar treatments for brain-based disorders may target immune inflammatory systems directly or indirectly. In this presentation, Dr. Roger McIntyre provides an update on the immune inflammatory system and its potential role in the pathology and treatment of mental illnesses.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Emerging Treatment Options for Tardive Dyskinesia
Andrew J Cutler, MD
Tardive dyskinesia (TD) is an ongoing concern for patients treated with antipsychotics. Discontinuation of antipsychotic treatment may offer the best chance of TD remission; however, alternative strategies of TD management must be employed in patients who require continued antipsychotic therapy. In this presentation, Dr. Andrew Cutler discusses new strategies for treating and managing tardive dyskinesia.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Somewhere Over the Rainbow: Recommendations for the Diagnosis and Treatment of Depressive Mixed States
Roger S McIntyre, MD, FRCPC
As many as 70% of patients may exhibit mixed features (subtle symptoms of (hypo)mania) during a major depressive episode. In this presentation, Dr. Roger McIntyre discusses the importance of identifying mixed features in patients with mood disorders as well as up-to-date strategies for managing depressive mixed states.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Good Vibrations: An Update on Stimulation Therapies; What’s Legitimate and What’s Not
William M Sauvé, MD
For patients with treatment-resistant depression, stimulation therapies such as cranial electrotherapy stimulation (CES), and transcranial magnetic stimulation (TMS) have significantly decreased depressive symptoms. Understanding which brain stimulation techniques may be most effective for the treatment of patients with different neuropsychiatric conditions, and knowing which TMS protocols are appropriate for special populations is important for clinicians. In this lecture, Dr. William Sauve’ presents the most current research on what brain stimulation techniques are effective treatment for depression and other neuropsychiatric conditions.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Beyond Monoamines: Novel Approaches to Antidepressant Treatment
Andrew J Cutler, MD
Our understanding of the neurobiology of depression has increased in recent years, there is recognition that the neurobiological substrates of depression may go beyond monoaminergic circuits. In this presentation, Dr. Andrew Cutler provides an update on novel antidepressant treatments that are recently available or in development, including the mechanisms of action that are thought to underlie their potential antidepressant effects.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|